Q Bio is a quantitative, clinically-relevant assessment of personal human health which gives you a deeper understanding of your body and how it’s changing, so you have more control over your health.

Q Bio makes it easier to identify signs of disease at the earliest stages, before symptoms arise.

Q Bio was founded in 2015 by Jeff Kaditz, Michael Snyder and Garry Choy. The company is headquartered in Redwood City, California.

 

Q Bio gives you a deeper understanding of your body and how it’s changing, so you have more control over your health. Q Bio’s platform is a quantitative, clinically-relevant assessment of personal human health.

 

Q Bio's Q Exam is based on landmark systems biology research done at Stanford University. In about 75 minutes, it takes blood, saliva, urine and a non-invasive whole-body scan from which it measures over 3000 clinically-relevant genetic, chemical, and anatomical biomarkers to build the world’s most comprehensive quantitative snapshot of your health at a point in time.

 

Q Bio is backed by Andreessen Horowitz, Khosla Ventures, Andreessen Horowitz and others. The company raised $40M in a Series B round on Feb 20, 2020. This brings Q Bio's total funding to $58M to date.

 

 

  • Year founded: 2015
  • Funding Info: $58M over 3 Rounds (Latest Funding Type: Series B)
  • Yearly Revenue: NA
  • Employee Size: 11-50
  • Business Valuation: NA
  • City/Town: Redwood City
  • State: California
  • Country: United States
Related businesses